Hartmut Retzlaff
Direttore/Membro del Consiglio presso Eurogenerics NV
Profilo
Hartmut Retzlaff is currently a Director at Clonmel Healthcare Ltd., STADA Financial Investments Ltd., STADA Pharmaceuticals (Asia) Ltd., and a Member-Supervisory Board at Eurogenerics NV, STADApharm AB, and Stada Vietnam J.V.
Co. Ltd.
He was formerly the Chairman-Management Board at STADA Arzneimittel AG from 1992 to 2016.
He also held positions as Chairman at Hemofarm AD, Director at OY Stada Pharma AB and SFS International Ltd., and Member-Supervisory Board at NeoCare NV.
Posizioni attive di Hartmut Retzlaff
| Società | Posizione | Inizio |
|---|---|---|
| Eurogenerics NV | Direttore/Membro del Consiglio | - |
Clonmel Healthcare Ltd.
 Clonmel Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Clonmel Healthcare Ltd. manufactures pharmaceutical products. Its prescription products therapeutic areas including CNS, cardiovascular, NSAID, gastro-intestinal and anti-infectives. The firm's products focus on women's and babies health, skincare and health supplements. The company was founded by T. O'Brien in 1970 and is headquartered in Dublin, Ireland. | Direttore/Membro del Consiglio | - |
| STADA Financial Investments Ltd. | Direttore/Membro del Consiglio | - |
| STADApharm AB | Direttore/Membro del Consiglio | - |
| STADA Pharmaceuticals (Asia) Ltd. | Direttore/Membro del Consiglio | - |
| Stada Vietnam J.V. Co. Ltd. | Direttore/Membro del Consiglio | 01/09/2013 |
Precedenti posizioni note di Hartmut Retzlaff
| Società | Posizione | Fine |
|---|---|---|
| STADA ARZNEIMITTEL | Amministratore Delegato | 05/06/2016 |
| SFS International Ltd. | Direttore/Membro del Consiglio | - |
| OY Stada Pharma AB | Direttore/Membro del Consiglio | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: MajorHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
| Eurogenerics NV | |
NeoCare NV
 NeoCare NV Pharmaceuticals: MajorHealth Technology Part of STADA Arzneimittel AG, NeoCare NV is a Belgian company that manufactures and supplies pharmaceuticals. The company is based in Brussels, Belgium. | Health Technology |
Hemofarm AD
 Hemofarm AD Pharmaceuticals: MajorHealth Technology Hemofarm AD engages in the manufacture, sale, and distribution of pharmaceutical products. The company was founded on June 1, 1960 and is headquartered in Vrsac, Serbia. | Health Technology |
| OY Stada Pharma AB | |
Clonmel Healthcare Ltd.
Clonmel Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Clonmel Healthcare Ltd. manufactures pharmaceutical products. Its prescription products therapeutic areas including CNS, cardiovascular, NSAID, gastro-intestinal and anti-infectives. The firm's products focus on women's and babies health, skincare and health supplements. The company was founded by T. O'Brien in 1970 and is headquartered in Dublin, Ireland. | Health Technology |
| SFS International Ltd. | |
| STADA Financial Investments Ltd. | |
| STADApharm AB | |
| STADA Pharmaceuticals (Asia) Ltd. | |
| Stada Vietnam J.V. Co. Ltd. |
- Borsa valori
- Insiders
- Hartmut Retzlaff
